文献速递皮肤肿瘤

胶带条RNA分析在临床疑似皮肤黑色素瘤中排除诊断的研究

RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study.
PubMed 文献 · J Am Acad Dermatol · 2023-05-22

研究纳入200例临床评估为皮肤恶性黑色素瘤的病变,切除前进行胶带条取样并检测11个基因表达。以PRAME和KIT两个癌基因相对管家基因的表达构建排除试验,结果检出全部73例黑色素瘤(100%敏感性),在127例非黑色素瘤中正确排除32%(32%特异性)。作者认为该技术可减少约三分之一良性病变的切除而不漏诊黑色素瘤,但需在独立试验中验证。

要点

  • 胶带条RNA检测对临床疑似黑色素瘤的排除试验敏感性为100%,检出全部73例黑色素瘤。
  • 该试验在127例非黑色素瘤病变中特异性为32%,可正确排除32%的良性病变。
  • 患者年龄和样本储存时间也是显著影响因素。

核心结论

  • 结果显示该技术可将良性病变的切除减少三分之一,且不漏诊任何黑色素瘤。
  • 作者指出需在独立试验中进行验证。

研究设计与样本

  • 诊断性研究,在手术切除前对200例临床评估为皮肤恶性黑色素瘤的病变进行胶带条取样。
  • 通过RNA测量研究胶带条上11个基因的表达水平,并用于排除试验。

主要发现

  • 组织病理学显示纳入73例皮肤恶性黑色素瘤和127例非皮肤恶性黑色素瘤。
  • 基于PRAME和KIT两个癌基因相对管家基因的表达水平,试验正确识别全部皮肤恶性黑色素瘤(100%敏感性)。
  • 患者年龄和样本储存时间也显著。
  • 同时,试验在32%的非皮肤恶性黑色素瘤病变中正确排除皮肤恶性黑色素瘤(32%特异性)。

关键数值与推荐

  • 排除试验基于PRAME和KIT两个癌基因相对管家基因的表达水平,敏感性100%,特异性32%。
  • 原文未报告具体阈值、剂量或推荐等级。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 样本中皮肤恶性黑色素瘤比例非常高,可能由于COVID-19关闭期间纳入。
  • 必须在独立试验中进行验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Distinguishing cutaneous malignant melanoma (CMM) from nevi can be clinically challenging. Suspicious lesions are therefore excised, resulting in many benign lesions being removed surgically to find 1 CMM. It has been proposed to use tape strip derived ribonucleic acid (RNA) to distinguish CMM from nevi. OBJECTIVE: To develop this technique further and validate if RNA profiles can rule out CMM in clinically suspicious lesions with 100% sensitivity. METHODS: Before surgical excision, 200 lesions clinically assessed as CMM were tape stripped. Expression levels of 11 genes on the tapes were investigated by RNA measurement and used in a rule-out test. RESULTS: Histopathology showed that 73 CMMs and 127 non-CMMs were included. Our test correctly identified all CMMs (100% sensitivity) based on the expression levels of 2 oncogenes, PRAME and KIT, relative to a housekeeping gene. Patient age and sample storage time were also significant. Simultaneously, our test correctly excluded CMM in 32% of non-CMM lesions (32% specificity). LIMITATIONS: Our sample contained a very high proportion of CMMs, perhaps due to inclusion during COVID-19 shutdown. Validation in a separate trial must be performed. CONCLUSION: Our results demonstrate that the technique can reduce removal of benign lesions by one-third without overlooking any CMMs.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Heerfordt IM, Philipsen PA, Andersen JD, et al. RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study. J Am Acad Dermatol. 2023. PMID: 37224970. doi:10.1016/j.jaad.2023.05.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。